Profile for Securities of PLC
KPOWER BERHAD
Instrument Category Securities of PLC
Instrument Type Warrants
Description Issuance of up to 150,774,529 warrants in KPower Berhad (formerly known as Kumpulan Powernet Berhad) ("KPower" or the "Company") ("Warrant(s) A") to the existing shareholders of KPower on the basis of 1 Warrant A for every 3 existing ordinary shares held in KPower held as at 5.00 p.m. on 13 January 2021
Listing Date 25 Jan 2021
Issue Date 20 Jan 2021
Issue/ Ask Price Not Applicable
Issue Size Indicator Unit
Issue Size in Unit 150,774,529
Maturity Mandatory
Maturity Date 19 Jan 2026
Revised Maturity Date
Name of Guarantor Not Applicable
Name of Trustee Not Applicable
Coupon/Profit/Interest/Payment Rate Not Applicable
Coupon/Profit/Interest/Payment Frequency Not Applicable
Redemption Not Applicable
Exercise/Conversion Period 5.00 Year(s)
Revised Exercise/Conversion Period
Exercise/Strike/Conversion Price Malaysian Ringgit (MYR) 2.5000
Revised Exercise/Strike/Conversion Price Not Applicable
Exercise/Conversion Ratio 1:1
Revised Exercise/Conversion Ratio
Mode of satisfaction of Exercise/ Conversion price Cash
Settlement Type/ Convertible into Physical (Shares)


Remarks :
Each Warrant A carries the entitlement to subscribe for 1 new KPower Share at the exercise price of RM2.50 and at any time during the exercise period of 5 years as indicated above ("Exercise Period") commencing from and including the issue date and ending at 5.00 p.m. on the expiry date (provided that if such a day is not a market day, then it shall be the market day immediately preceding the said non-market day). The Warrants A are subject to the adjustments in accordance with the provisions of the deed poll dated 28 December 2020 constituting the Warrants A. Any Warrants A not exercised during the Exercise Period will thereafter lapse and cease to be valid for any purpose.


This announcement is dated 22 January 2021.
Announcement Info
Company Name KPOWER BERHAD
Stock Name KPOWER-WA
Date Announced 22 Jan 2021
Category Listing Information and Profile
Reference Number LIP-22012021-00041

Profile for Securities of PLC | https://www.klsescreener.com/v2/announcements/view/3296401

KUALA LUMPUR, Dec 22 — The Malaysian government has entered an agreement to purchase 6.4 million doses of a Covid-19 vaccine from pharmaceutical firm AstraZeneca, Prime Minister Tan Sri Muhyiddin Yassin announced today.

He also said the government was in advanced talks to procure additional doses of comparable vaccines from Sinovac, CanSino and Gamaleya.

Science, Technology and Innovation Minister Khairy Jamaluddin, who was at today’s signing ceremony, said Malaysia was now on track to secure enough vaccines to surpass the rate needed for herd immunity against Covid-19.

“After signing deals with Covax, Pfizer & AstraZeneca and finalising agreements with Sinovac, CanSino & Gamaleya, we will have vaccines for almost 83 per cent of our population at RM 2.05 billion,” Khairy said on Twitter.

“With this announcement, I hope it clears up the misinformation spread by [Lim Kit Siang] that we spent RM3 billion on just the Pfizer deal alone that covers 20 per cent of our population.”

After the signing, Muhyiddin said the doses from AstraZeneca represent vaccination coverage for another 10 per cent of the Malaysian population, which meant the government has now secured enough of the vaccines for 40 per cent of the country.

Malaysia previously entered agreements to purchase vaccines for 30 per cent of the country from Pfizer-Biontech and Covax.

“The government is also in final negotiations with Sinovac, CanSino and Gamaleya to secure a vaccine supply increase of more than 80 per cent or 26.5 million of the country's total population,” Muhyiddin was quoted as saying by state news agency Bernama.

The government previously set the target to vaccinate at least 70 per cent of Malaysia in order to achieve herd immunity against Covid-19.

Muhyiddin said the agreements with Sinovac, CanSino and Gamaley also included knowledge transfer that would help develop Malaysia’s science and technology sectors.

The prime minister then reiterated that Malaysia’s health authorities would thoroughly evaluate all Covid-19 vaccines to be used here for safety and effectiveness before they were deployed.

Earlier, the PM also said he would be among the first in the country to receive a Covid-19 vaccine, in order to help convince Malaysians that these were safe

KUALA LUMPUR (Dec 3): Sarawak Consolidated Industries Bhd (SCIB) has bagged two engineering, procurement, construction and commissioning contracts for an estimated total value of RM271.1 million.

The contracts, one in Sarawak and the other in the Gulf nation of Qatar, have increased the group’s order book to RM1.7 billion, the integrated civil construction group said.

“It has also allowed us to achieve our internal order book target of RM1.5 billion for 2020,” SCIB managing director and CEO Rosland Othman said in a statement today.

SCIB said the first contract was awarded by Dermaga Makmur Sdn Bhd for the construction of a new school with 12 classrooms, six units of residences for teachers and other facilities at Sekolah Kebangsaan Kalor in Betong with an estimated contract value of RM18.3 million. The project is expected to be completed in March 2022.

The second contract was awarded by Pavilion Qatar Engineering Co. W. L.L. for a civil works fire water project at the Ras Laffan Industrial City Power Station with an estimated contract value of US$62 million (RM252.84 million). The project is expected to be completed in November 2021.

“These successful bids are expected to improve our earnings for the next 12- to 18 months and also now that we are actively expanding our domestic construction activities. We hope to pursue other projects locally in the coming year, that allow us to roll out more infrastructure developments for Rakyat’s welfare,” Rosland added.

Shares of SCIB closed two sen or 0.43% higher at RM4.69 today, for a market capitalisation of RM575.15 million.